Mingchen Health (002919) Shareholder Wu Xinling Plans to Reduce Holdings of No More Than 7.9 Million Shares, Accounting for 3% of Total Share Capital

Log in to Sina Finance App and search for [Information Disclosure] to see more evaluation levels.

On March 21, 2026, Mingchen Health Products Co., Ltd. (hereinafter referred to as “Mingchen Health” or “the Company”) announced that the shareholder Wu Xinling, holding more than 5% of the shares, plans to reduce their holdings through centralized bidding and block trades, with a total reduction of no more than 7.9 million shares, accounting for 3% of the company’s total share capital.

Key Content of the Reduction Plan

The announcement states that Wu Xinling’s reason for the reduction is personal financial needs. The shares are sourced from market transfer agreements and subsequent capital reserve converted into share capital.

Regarding specific reduction arrangements, Wu Xinling plans to reduce no more than 2.63 million shares through centralized bidding, accounting for 0.9952% of the total share capital; and no more than 5.27 million shares through block trades, accounting for 1.9941% of the total share capital, for a total reduction of no more than 7.9 million shares, or 3% of the total share capital. If the company issues bonus shares or increases capital from capital reserves during this period, the reduction amount will be adjusted accordingly.

The reduction period is within three months after 15 trading days from the date of this announcement, i.e., from April 10, 2026, to July 9, 2026. If legal or regulatory conditions arise during this period, the reduction will not be carried out. The reduction price will be determined based on market prices.

Background and Impact Analysis of the Reduction

According to the announcement, Wu Xinling currently holds 14.6632 million shares of Mingchen Health, accounting for 5.5% of the company’s total share capital, making her an important shareholder holding more than 5%. After implementing this reduction plan, her shareholding ratio will decrease to no less than 2.5% (if the maximum reduction is applied).

Mingchen Health emphasized in the announcement that this reduction plan will not lead to a change in the company’s control, nor will it have a significant impact on corporate governance or ongoing operations. Wu Xinling’s reduction does not involve any breach of commitments, and the behavior complies with the Securities Law, Shenzhen Stock Exchange Stock Listing Rules, and other laws, regulations, and normative documents.

Risk Reminder

The announcement also reminds that Wu Xinling will decide whether to implement or partially implement this reduction plan based on her own situation, market conditions, and the company’s stock price. Therefore, there is uncertainty regarding the timing, amount, and price of the reduction. The company will strictly comply with relevant regulations and fulfill information disclosure obligations in a timely manner.

Mingchen Health reminds investors to invest rationally and be aware of investment risks.

Disclaimer: The market carries risks; investment should be cautious. This article is automatically published by an AI large model based on third-party databases and does not represent Sina Finance’s views. Any information appearing herein is for reference only and does not constitute personal investment advice. Please refer to the actual announcement for accuracy. If you have any questions, contact biz@staff.sina.com.cn.

Click to view the original announcement>>

Massive information, precise interpretation, all on Sina Finance App.

Editor: Xiao Lang Kuai Bao